Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,154 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A placebo randomized controlled study to test the efficacy and safety of GNbAC1, a monoclonal antibody for the treatment of multiple sclerosis - Rationale and design.
Curtin F, Porchet H, Glanzman R, Schneble HM, Vidal V, Audoli-Inthavong ML, Lambert E, Hartung HP. Curtin F, et al. Among authors: lambert e. Mult Scler Relat Disord. 2016 Sep;9:95-100. doi: 10.1016/j.msard.2016.07.002. Epub 2016 Jul 1. Mult Scler Relat Disord. 2016. PMID: 27645352 Clinical Trial.
Efficacy and safety of temelimab in multiple sclerosis: Results of a randomized phase 2b and extension study.
Hartung HP, Derfuss T, Cree BA, Sormani MP, Selmaj K, Stutters J, Prados F, MacManus D, Schneble HM, Lambert E, Porchet H, Glanzman R, Warne D, Curtin F, Kornmann G, Buffet B, Kremer D, Küry P, Leppert D, Rückle T, Barkhof F. Hartung HP, et al. Among authors: lambert e. Mult Scler. 2022 Mar;28(3):429-440. doi: 10.1177/13524585211024997. Epub 2021 Jul 9. Mult Scler. 2022. PMID: 34240656 Free article. Clinical Trial.
Bumetanide Oral Liquid Formulation for the Treatment of Children and Adolescents with Autism Spectrum Disorder: Design of Two Phase III Studies (SIGN Trials).
Crutel V, Lambert E, Penelaud PF, Albarrán Severo C, Fuentes J, Rosier A, Hervás A, Marret S, Oliveira G, Parellada M, Kyaga S, Gouttefangeas S, Bertrand M, Ravel D, Falissard B. Crutel V, et al. Among authors: lambert e. J Autism Dev Disord. 2021 Aug;51(8):2959-2972. doi: 10.1007/s10803-020-04709-8. J Autism Dev Disord. 2021. PMID: 33151500 Free PMC article. Clinical Trial.
Correction to: Bumetanide Oral Liquid Formulation for the Treatment of Children and Adolescents with Autism Spectrum Disorder: Design of Two Phase III Studies (SIGN Trials).
Crutel V, Lambert E, Penelaud PF, Albarrán Severo C, Fuentes J, Rosier A, Hervás A, Marret S, Oliveira G, Parellada M, Kyaga S, Gouttefangeas S, Bertrand M, Ravel D, Falissard B. Crutel V, et al. Among authors: lambert e. J Autism Dev Disord. 2021 Aug;51(8):2973. doi: 10.1007/s10803-020-04822-8. J Autism Dev Disord. 2021. PMID: 33423216 Free PMC article. No abstract available.
The utility of physical activity questionnaires among African origin populations; lost in translation?
Davies JC, Choo-Kang C, Soepnel L, Geffen H, Mtintsilana A, Africa C, Bovet P, Viswanathan B, Bedu-Addo K, Boateng PO, Apusiga K, Dei OA, Forrester TE, Lambert EV, Sinyanya N, Layden BT, Gilbert JA, Ecklu-Mensah G, Joyce C, Luke A, Dugas LR. Davies JC, et al. Among authors: lambert ev. Res Sq [Preprint]. 2024 Dec 12:rs.3.rs-5529358. doi: 10.21203/rs.3.rs-5529358/v1. Res Sq. 2024. PMID: 39711553 Free PMC article. Preprint.
Clustering of diet and physical activity behaviours in adolescents across home and school area-level deprivation in Cameroon, South Africa, and Jamaica.
Wasnyo Y, Tatah L, Wayas FA, Mapa-Tassou C, Luan J, Micklesfield LK, Smith JA, Farr C, Foley L, Lambert EV, Mbanya JC, Assah F, Oni T. Wasnyo Y, et al. Among authors: lambert ev. BMC Public Health. 2024 Nov 21;24(1):3234. doi: 10.1186/s12889-024-20683-7. BMC Public Health. 2024. PMID: 39574052 Free PMC article.
1,154 results